THERAVANCE INC's ticker is and the CUSIP is 88338TAB0. A total of 29 filers reported holding THERAVANCE INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $8,205,273,000 | +223.3% | 8,326,000 | +228.3% | 0.01% | +225.0% |
| Q1 2021 | $2,537,598,000 | +207.4% | 2,536,000 | +205.5% | 0.00% | +100.0% |
| Q4 2020 | $825,535,000 | +3.9% | 830,000 | 0.0% | 0.00% | +100.0% |
| Q3 2020 | $794,368,000 | -90.2% | 830,000 | -89.9% | 0.00% | -92.9% |
| Q2 2020 | $8,076,626,000 | +6.2% | 8,184,000 | 0.0% | 0.01% | -12.5% |
| Q1 2020 | $7,608,174,000 | +519.2% | 8,184,000 | +567.5% | 0.02% | +700.0% |
| Q4 2019 | $1,228,673,000 | +198.1% | 1,226,000 | +179.3% | 0.00% | +100.0% |
| Q3 2019 | $412,111,000 | -80.3% | 439,000 | -78.0% | 0.00% | -75.0% |
| Q2 2019 | $2,095,402,000 | +61.5% | 1,998,000 | +56.2% | 0.00% | +33.3% |
| Q1 2019 | $1,297,546,000 | +158.8% | 1,279,000 | +175.6% | 0.00% | +200.0% |
| Q4 2018 | $501,412,000 | +21.6% | 464,000 | +14.0% | 0.00% | 0.0% |
| Q3 2018 | $412,344,000 | +4.4% | 407,000 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $394,859,000 | – | 407,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 41,771 | $44,921,000 | 2.37% |
| LINDEN ADVISORS LP | 45,495,000 | $48,853,000 | 1.16% |
| BASSO CAPITAL MANAGEMENT, L.P. | 4,759,000 | $5,092,000 | 0.94% |
| SSI INVESTMENT MANAGEMENT LLC | 6,850,000 | $7,332,000 | 0.60% |
| TEALWOOD ASSET MANAGEMENT INC | 1,390,000 | $1,492,000 | 0.59% |
| Castle Creek Arbitrage, LLC | 6,070,000 | $6,516,000 | 0.48% |
| OAKTREE CAPITAL MANAGEMENT LP | 21,717,000 | $23,355,000 | 0.37% |
| AQR Arbitrage LLC | 27,018,000 | $29,055,000 | 0.34% |
| CSS LLC/IL | 5,000,000 | $5,360,000 | 0.27% |
| CQS Cayman LP | 4,150,000 | $4,469,000 | 0.21% |